Article

Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T Cells

2019-07-22

Abstract excerpt

Chimeric antigen receptor T (CAR-T) cell therapy is a cutting edge and potentially revolutionary new treatment option for cancer. However, there are significant limitations to its widespread use in the treatment of cancer. These limitations include the development of unique toxicities such as cytokine release syndrome (CRS) and neurotoxicity (NT) and limited expansion, effector functions, and anti-tumor activity i...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 51b56dff-4abe-5660-b7bd-70be31f3c3c4
DOI: 10.3791/59629-v

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T CellsDOI 10.3791/59629-vRead

Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T CellsSemantic proximity Read

RNA silencing of GM-CSF in CAR-T cells reduces the secretion of multiple inflammatory cytokinesSemantic proximity Read

Engineering the next-generation of CAR T-cells with CRISPR-Cas9 gene editingSemantic proximity Read

Efficient Gene Editing of CART Cells with CRISPR-Cas12a for Enhanced Antitumor EfficacySemantic proximity Read

CRISPR/Cas9-based genome editing in the era of CAR T cell immunotherapySemantic proximity Read

CRISPR/Cas9 edited tumor-associated immune cells in cancer immunotherapySemantic proximity Read

Using CRISPR to enhance T cell effector function for therapeutic applicationsSemantic proximity Read

Strengthening the CAR-T Cell Therapeutic Application using CRISPR/Cas9 TechnologySemantic proximity Read

Therapeutic potential of CRISPR/Cas9 gene editing in engineered T‐cell therapySemantic proximity Read

CRISPR/Cas9-Mediated Knockout of DGK Improves Antitumor Activities of Human T CellsSemantic proximity Read

Building Potent Chimeric Antigen Receptor T Cells With CRISPR Genome EditingSemantic proximity Read

CRISPR/Cas9‐edited tumor‐associated immune cells in cancer immunotherapySemantic proximity Read